Chargement en cours...
Development of Novel Immunotherapies for Multiple Myeloma
Multiple myeloma (MM) is a disorder of terminally differentiated plasma cells characterized by clonal expansion in the bone marrow (BM). It is the second-most common hematologic malignancy. Despite significant advances in therapeutic strategies, MM remains a predominantly incurable disease emphasizi...
Enregistré dans:
| Publié dans: | Int J Mol Sci |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5037783/ https://ncbi.nlm.nih.gov/pubmed/27618026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17091506 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|